Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner.

Source:http://linkedlifedata.com/resource/pubmed/id/17881452

Download in:

View as

General Info

PMID
17881452